论文部分内容阅读
目的:研究丹参注射液对脑梗死患者的临床治疗效果。方法:选取2014年4月~2015年4月收治的65例脑梗死患者为研究对象,根据治疗方式不同定义为两组,对照组32例行常规西医治疗,观察组33例在对照组的基础上加用丹参注射液治疗,对比两组临床疗效。结果:观察组患者治疗总有效率(87.88%)明显高于对照组患者的治疗总有效率(62.5%),P<0.05,差异显著,具有统计学意义,且观察组患者血流变学指标恢复情况均优于对照组,两组治疗后组间比较,#P<0.05,统计学差异具有显著意义。结论:临床脑梗死患者常规治疗中加用丹参注射液治疗明显改善患者血流变学指标,促进病情预后,具有较高的临床使用价值。
Objective: To study the clinical effect of Danshen injection on patients with cerebral infarction. Methods: Sixty-five patients with cerebral infarction who were treated from April 2014 to April 2015 were selected as the study subjects. Two groups were defined according to the different treatment methods. The control group received conventional western medicine treatment and the control group received 33 cases. On the increase with Salvia injection treatment, the two groups compared the clinical efficacy. Results: The total effective rate (87.88%) in the observation group was significantly higher than that of the control group (62.5%), P <0.05, the difference was statistically significant, and the hemorrheological indexes Recovery were better than the control group, the two groups after treatment comparison, # P <0.05, statistically significant difference. Conclusion: The treatment of patients with clinical cerebral infarction with Salvia miltiorrhiza injection can significantly improve the hemorheology indexes and promote the prognosis of patients with high clinical value.